AHMEDABAD, India, July 8, 2025 /PRNewswire/ -- Veeda Lifesciences, a global contract research organization (CRO), has announced an investment in Mango Sciences, a Boston-based healthcare AI and data ...

AHMEDABAD, India, Jan. 2, 2025 /PRNewswire/ -- Veeda Group has unveiled a new logo and brand identity—Veeda Lifesciences—marking a key milestone in its journey. The new brand name reflects the ...

In March, Veeda Clinical Research, acquired a significant minority stake in Bengaluru-based pre-clinical research firm Bioneeds India Pvt. Ltd.(HT) CX partners backed Veeda Clinical Research on ...

Of the proceeds from the issue, ₹28.71 crore will be used to repay debt incurred by Veeda’s arm Bioneeds. Veeda Clinical Research Ltd on Wednesday draft papers for a ₹831.6 crore initial public ...

Veeda Clinical Research Limited has received clearance from the Securities and Exchange Board of India (SEBI) to file its initial public offering (IPO), with private equity firm CX Partners making a ...

DUBLIN and AHMEDABAD, India, March 26, 2024 /PRNewswire/ -- Veeda Clinical Research Limited, a full-service contract research organization (CRO) with a proven record of drug development success, ...

Anglo-Indian contract research organisation (CRO) Veeda Clinical Research has launched Veeda Oncology as a vehicle to provide oncology clinical research services to the pharmaceutical and ...

Veeda Clinical Research, an Anglo-Indian contract research organisation (CRO) formed in October 2005, has acquired a Phase I clinical research unit in Görlitz, eastern Germany. Veeda Clinical Research ...

Mumbai: Ahmedabad-based Veeda Clinical Research, a contract/clincal research organisation (CRO), has acquired a controlling 50.1% stake in Bengaluru-based pre-clinical CRO Bioneeds for an undisclosed ...

Veeda Lifesciences, a global contract research organization (CRO), has announced an investment in Mango Sciences, a Boston-based healthcare AI and data company. Through this investment, Veeda intends ...